thalidomide has been researched along with Adolescent Gynecomastia in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pulik, M | 1 |
Genet, P | 1 |
Lionnet, F | 1 |
Touahri, T | 1 |
Mourad, YA | 1 |
Shamseddine, A | 1 |
Taher, A | 1 |
Schmidt, M | 1 |
Salzano, FM | 1 |
1 review available for thalidomide and Adolescent Gynecomastia
Article | Year |
---|---|
Thalidomide-associated gynecomasty in a patient with multiple myeloma.
Topics: Aged; Gynecomastia; Humans; Multiple Myeloma; Remission Induction; Thalidomide | 2003 |
2 other studies available for thalidomide and Adolescent Gynecomastia
Article | Year |
---|---|
Thalidomide-associated gynecomasty in a patient with multiple myeloma.
Topics: Gynecomastia; Humans; Male; Middle Aged; Multiple Myeloma; Thalidomide | 2002 |
Clinical studies on teenage Brazilian victims of thalidomide.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adolescent; Brazil; Child; Female; Gynecomasti | 1983 |